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http://dxObjective: Although the technique of totally endoscopic robotic mitral valve repair (TERMR) has been well
described, few reports have examined the results of peripheral perfusion with balloon clamping. We analyzed
the outcomes of TERMR performed using this strategy.
Methods: A total of 108 consecutive patients underwent TERMR by a 2-surgeon team. The preoperative
evaluation included chest computed tomography and abdominal and pelvis computed tomography. Additional
procedures included appendage exclusion in 96, patent foramen ovale closure in 29, cryoablation in 16, tricuspid
valve repair in 2, and septal myectomy in 2. The mean patient age was 59 years (range, 21-86). Central venous
drainage was obtained with a long cannula. Arterial return was achieved with femoral cannulation, when
possible. An endoballoon catheter was placed through the femoral artery. Transesophageal echocardiography
was used to position all catheters.
Results: Femoral artery perfusion was possible in 103 of 108 patients (95.3%). The subclavian artery was used
in 5 patients (4.6%) with contraindications to retrograde perfusion. An endoballoon clamp was placed by way of
the femoral artery. In 105 of 108 patients (97.2%), endoaortic occlusion was successfully used; the mean
crossclamp time was 87.4 minutes. The coronary sinus cardioplegia catheter was placed successfully in 81 of
the 108 patients (75%). Postoperatively, no or mild inotropic support was needed in 94 (87%) and moderate
support in 14 (13.0%). Of the 108 patients, 55 (50.9%) were extubated in the operating room. No hospital
mortality, aortic injury, vascular complications, or wound infections occurred. Complications included 2 strokes
(no residual deficit) (1.8%) and atrial fibrillation in 18 (16.7%). The median hospital stay was 4 days. Eighty
patients (74.1%) were discharged by postoperative day 5.
Conclusions: A preoperative image-guided perfusion strategy and aortic balloon clamping permit routine
TERMR with excellent myocardial preservation and minimal complications. (J Thorac Cardiovasc Surg
2014;148:2769-72)A
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DAdvances in techniques, combined with an increasing
demand for less invasive mitral valve surgery, have resulted
in robotic mitral valve repair evolving into a useful surgical
option that allows for precise and durable repair with
smaller surgical incisions.1-4 The first report of robotic-
assisted mitral valve surgery used a minithoracotomy
approach,5 with subsequent investigators confirming the
feasibility of this technique.6-11 During the previous
decade, 2 distinct perfusion and crossclamping
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The Journal of Thoracic and Carthat relies on external aortic crossclamping and one that
uses endoballoon technology (Edwards Lifesciences,
Irvine, Calif) for aortic clamping. Several large groups
have continued to use minithoractomy with external aortic
crossclamping as a mainstay approach.1,12 A second
perfusion and clamping paradigm for robotic repair has
evolved to a totally endoscopic approach (totally
endoscopic robotic mitral valve repair [TERMR]) with
the working port sized to only accept a single finger.
Advocates of this approach have tended to rely on
endoballoon clamping, because this technique avoids the
necessity of placing a needle in the ascending aorta for
cardioplegia delivery and aortic root venting. Although
Murphy and colleagues13 initially described this technique,
few current era reports of TERMR with endoaortic balloon
occlusion have been published.2,10,14 The purpose of the
present study was to analyze our outcomes with an
imaging-guided peripheral perfusion strategy with balloon
aortic clamping for TERMR.METHODS
From May 2011 to September 2013, 108 consecutive patients
underwent TERMR by a dedicated 2-surgeon team. A 3-month hiatus
(October 29, 2012 to January 2013) occurred owing to infrastructure lossesdiovascular Surgery c Volume 148, Number 6 2769
Abbreviations and Acronyms
LIMV ¼ less-invasive mitral valve surgery
TEE ¼ transesophageal echocardiography
TERMR ¼ totally endoscopic robotic mitral valve
repair
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Dfrom Hurricane Sandy. All TERMRs were performed using the da Vinci Si
Surgical System (Intuitive Surgical, Inc, Sunnyvale, Calif). Our dedicated
robotic surgery team consisted of 2 experienced mitral valve surgeons, 1
cardiac anesthesiologist, 1 perfusionist, and 2 operating room nurses.15
Both surgeons had extensive previous experience with the balloon aortic
clamping technology. Our routine preoperative workup strategy included
vascular evaluation with chest computed tomography angiography in 95
of 108 patients (88%) and abdominal and/or pelvic computed tomography
angiography in 98 (90.7%). All patients also underwent intraoperative
transesophageal echocardiography (TEE), performed either by the cardiac
anesthesiologist or the dedicated operating room echocardiologist. The
average patient age was 59 years (range, 21-86); 19 patients (17.6%)
were>70 years old; 41 (38%) were women. In addition to TERMR, other
robotic procedures performed at the time of repair included oversewing of
the left atrial appendage in 96, patent foramen ovale closure in 29, cryoa-
blation in 16, tricuspid valve repair in 2, and septal myectomy in 2. Of the
108 patients, 4 (3.7%) had previously undergone cardiac surgery—2 cor-
onary artery bypass grafting, 1 coronary artery bypass grafting and aortic
valve replacement, and 1 atrial septal defect closure. Aortic insufficiency
was absent in 88 patients (81.4%), 13 (12.0%) had mild aortic
insufficiency, and 7 (6.5%) had mild to moderate aortic insufficiency.
All patients, except for 1, underwent placement of a band annuloplasty
device with an interrupted suture technique. The average band size was
34.4 mm (range, 26-38). The patient and procedural demographics are
listed in Table 1.
In all cases, central venous drainage was obtained with a long cannula
introduced through the femoral vein. Arterial return was achieved with
small femoral artery cutdown for exposure and cannulation.16 An
endoballoon catheter was placed through the femoral arterial return
cannula; this catheter provided aortic occlusion, antegrade cardioplegia,
and root venting. Additionally, a coronary sinus cardioplegia catheter
was introduced through the internal jugular vein. With routine placement,
our anesthesia team was very proficient at this technique, adding minimal
time to the operation. All catheters were placed using the Seldinger
technique, and TEE was used to position the catheters; fluoroscopy was
not used.17 At the end of the case and after removal of the femoral cannula,
the artery was repaired with 6-0 polypropylene suture.RESULTS
Retrograde perfusion by way of the femoral artery was
achieved in 103 of the 108 patients (95.4%). Retrograde
perfusion was not used in the presence of mobile aortic
atheroma, extensively calcified aortas, occlusive peripheral
vascular disease, iliac vessel dissection, or a small vessel
size (<6 mm). Antegrade perfusion by way of the subcla-
vian artery was used in 5 patients (4.6%). Of the 108
patients, 105 (97.2%) had an endoballoon catheter placed
by way of the femoral arterial return cannula. The mean
cardiopulmonary bypass time was 123 minutes (range,
60-229), and the mean crossclamp time was 87 minutes
(range, 30-178). Three operations were performed with
ventricular fibrillation. A coronary sinus cardioplegia2770 The Journal of Thoracic and Cardiovascular Surcatheter was successfully placed in 81 patients (75.0%),
and retrograde cardioplegia was delivered in 79 (73.1%).
Del Nido cardioplegia was the preferred cardioplegia; we
began using it in May 2013, and it has since been used
consecutively in 34 patients (31.5%).
Of the 108 patients, 55 (50.9%) were extubated in the
operating room, and 104 (96.3%) were extubated within
24 hours. Of the last 50 patients in this group, 40 (80.0%)
were extubated in the operating room. Postoperatively, no
inotropic support was needed in 58 patients (53.7%),
mild support was used in 36 (33.3%), and moderate support
in 14 (13.0%). One patient required intra-aortic balloon
pump placement postoperatively for decreased left
ventricular function, recovered, and was discharged with
an ejection fraction of 50%. No ventricular assist devices
were used. No hospital mortalities occurred. No aortic
injuries or peripheral vascular complications and no wound
infections developed. Three patients (2.8%) developed a
groin seroma. Two minor strokes (1.8%) occurred, without
residual defects. One patient experienced transient
left-sided numbness; magnetic resonance imaging revealed
an acute infarct of the anterior and middle cerebral artery
watershed territories. Another patient experienced partial
aphasia for 24 hours; a small embolic infarct of the left
posterior parietal lobe was noted on magnetic resonance
imaging. Both of these patients had undergone retrograde
perfusion and endoaortic balloon occlusion. Both patients
had required complex repairs, with long cardiopulmonary
bypass (229 and 152 minutes) and crossclamp (113 and
161 minutes) times. Eighteen patients (16.7%) developed
atrial fibrillation. One patient was returned to the operating
room because of postoperative bleeding; right thoracotomy
was performed using the initial working port incision, and
the patient was cannulated femorally. Exploration revealed
a right atrial tear, which was repaired with pledgets. The
median hospital length of stay was 4 days, and 80 patients
(74.1%) were discharged by postoperative day 5.
In addition to these patient-related complications, 2
isolated robot incidents occurred that did not result in
adverse patient outcomes. The first occurred when a fluid-
filled canister spilled onto the robot tower at the beginning
of the case and incapacitated a control board. A replacement
tower was swapped in, and the case was continued as
planned. Another robotic event occurred when the robot
was accidentally unplugged during left atrial closure. The
instruments were withdrawn, the robot restarted, and the
procedure continued within 4 minutes.
DISCUSSION
Two primary approaches for robotic mitral valve surgery
are currently favored: minithoracotomy with external aortic
crossclamping1,12,18-21 and total endoscopic mitral repair
using endoballoon technology.2,10,13 Our findings have
confirmed the safety of an image-guided retrogradegery c December 2014
TABLE 1. Patient and procedure demographics
Variable n (%)
Previous cardiac surgery 4 (3.7)
Additional procedures
Cryoablation 16 (14.8)
Left atrial appendage exclusion 96 (88.9)
PFO closure 29 (26.8)
Septal myectomy 2 (1.8)
Tricuspid valve repair 2 (1.8)
Degree of aortic insufficiency
None 88 (81.5)
Mild 13 (12.0)
Mild to moderate 7 (6.5)
Age (y)
21-30 5 (4.6)
31-40 4 (3.7)
41-50 15 (13.9)
51-60 28 (25.9)
61-69 37 (34.3)
70 19 (17.6)
Gender
Male 67 (62.0)
Female 41 (38.0)
Annuloplasty band placed 107 (99.0)
Annuloplasty band size* (mm)
26 7 (6.5)
28 5 (4.7)
30 8 (7.4)
32 14 (13.1)
34 14 (13.1)
36 23 (21.5)
38 36 (33.6)
PFO, Patent foramen ovale. *Percentages for band size are percentages of total
number of bands placed.
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Dperfusion strategy with aortic endoclamping in those
patients undergoing robotic mitral valve surgery. Neverthe-
less, debate is still ongoing regarding whether retrograde
arterial perfusion leads to greater rates of complications
compared with antegrade arterial perfusion and whether
endoaortic balloon clamping is more prone to complica-
tions than external aortic crossclamping.
Our initial report of 714 minimally invasive mitral
operations (1995-2001) relied on retrograde perfusion in
79%. The incidence of permanent neurologic deficit was
2.9%, and retrograde perfusion was not found to be a risk
factor for neurologic sequelae on multivariable analysis.22
It is important to note that the present series was performed
without dedicated vascular imaging, relying solely on
clinical and intraoperative TEE evaluation of the vascula-
ture. Gammie and colleagues23 compared less-invasive
mitral valve surgery (LIMV) with a sternotomy approach
in the Society of Thoracic Surgeons database. LIMV was
defined by the cannulation strategy (femoral or jugular vs
central). Their report noted a markedly greater rate of
stroke associated with LIMV in unadjusted, adjusted, andThe Journal of Thoracic and Carpropensity analyses, with an adjusted odds ratio of 1.96.
Femoral cannulation was not an independent predictor of
stroke, although nonaortic clamping approaches were
significant contributors to greater stroke rates. The use of
the endoballoon compared with direct aortic crossclamping
was associated with a significantly greater rate of stroke in
the nonrobotic group, with an adjusted odds ratio of 2.34,
but not in the robotic LIMV subset. At our institution, in
a series of >3000 nonscreened mitral valve operations,
multivariable analysis revealed that age, an atherosclerotic
aorta, cerebrovascular disease, an emergency procedure,
an ejection fraction <30%, no aortic clamping, and
retrograde perfusion were significantly associated with
stroke. However, in patients <50 year old, retrograde
perfusion had no significant effect on the incidence of
stroke.24 Subsequent logistic regression with bootstrapping
analysis of 1282 patients who had undergone minimally
invasive isolated mitral valve repair at our institution
(30.7% retrograde perfusion, 29.1% endoaortic balloon
occlusion) demonstrated that a significant risk factor for
the occurrence of neurologic events was the use of
retrograde perfusion in high-risk patients with diseased
aortas.25 The present work has guided our understanding
of the risks of retrograde perfusion and helped us to develop
our current image-guided perfusion strategy, which has led
to low rates of neurovascular complications. These findings
are in alignment with the series of Murphy and colleagues13
of 127 patients undergoing TERMR with femoral perfusion
and endoaortic balloon occlusion. In their series, the
incidence of stroke was 1.6%, and no aortic injuries
occurred.13 Similarly, Casselman and colleagues26 treated
187 patients who underwent totally endoscopic mitral valve
repair with femoral perfusion and endoaortic balloon
occlusion. One patient experienced an aortic dissection
and stroke; no other patients developed any neurologic
events. Atluri and colleagues27 retrospectively examined
all patients at their institution who had undergone ‘‘port-
access’’ mitral valve operations from 1998 to 2012. Their
findings were presented at the recent 2014 Society of
Thoracic Surgeons presentation. Aortic occlusion with a
Chitwood clamp was used in 189 compared with 875 who
underwent endoaortic balloon occlusion. No difference
was found in the rate of aortic injury between the 2 groups.
No peripheral vascular complications occurred with either
strategy, and no difference was found in the rate of
neurologic complications.27 Significantly, when stratified
by the learning curve, a significant decrease was seen in
the aortic complications with experience.
Study Limitations
The limitations of the present study were primarily those
of a single-center experience; however, its strength was that
the institution had a decade’s experience with various
approaches for minimally invasive mitral valve surgery.diovascular Surgery c Volume 148, Number 6 2771
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DCONCLUSIONS
With appropriate preoperative vascular screening using
computed tomography angiography of the chest, abdomen,
and pelvis, in addition to intraoperative TEE, we can deter-
mine a perfusion plan according to the anatomy, quality,
and size of the aorta and peripheral vessels to minimize
neurovascular sequelae. When a hostile aorta is encountered,
subclavian perfusion will be appropriate for TERMR. A pre-
operative image-guided perfusion strategy and aortic balloon
clampingwill permit routine TERMRwith excellentmyocar-
dial preservation and minimal complications.
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